Article
Germline Testing for the Evaluation of Hereditary Cancer Predisposition.
Clinics in laboratory medicine - 1 Sept 2022
Ceyhan-Birsoy Ozge
Abstract excerpt
Germline testing for hereditary cancer predisposition has become increasingly important in the management of patients with cancer. Recent studies have demonstrated that hereditary cancer predisposition is more common than previously recognized and germline pathogenic variants may be actionable for patient treatment strategies. This article reviews the significance of hereditary cancer predisposition assessment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
